XML 37 R11.htm IDEA: XBRL DOCUMENT

EQUITY	12 Months Ended
Feb. 28, 2013
Equity [Abstract]
Note 5. EQUITY	As referenced in Note 3, the MBM issued 3,290,570 shares of common stock for the partial compensation due to the Licensors pursuant to the License Agreement. The Company accounted for this as a research and development expense valued at $74,786. During February 2012, MBM issued an aggregate of 160,158 shares of common stock to the Licensors in connection with the anti-dilution rights to maintain a certain ownership percentage in the Company. The shares were valued at $72,799. During the year ended February 29, 2012, MBM sold 2,989,043 shares of common stock for total proceeds of $1,943,324. On February 27, 2012, we entered into the Exchange Agreement with MBM by issuing 18,369,421 shares of our common stock in exchange for the MBM Shares. Immediately prior to the Share Exchange, we had 840,000 shares outstanding which have been recorded as recapitalization of shareholders on MetaStat’s books at par. During the year ended February 29, 2012, we sold 865,000 shares of common stock for proceeds of $865,000, however, $865,000 was received subsequent to February 29, 2012 and we disclosed the balance as a subscription receivable on our balance sheet as of February 29, 2012. During the year ended February 28, 2013, the Company sold 880,000 shares of common stock for total proceeds of $880,000. Additionally, the Company issued 100,000 shares of restricted common stock to members of the board of directors for services for total expense of $5,270.

EQUITY

12 Months Ended

Feb. 28, 2013

As referenced in Note 3, the MBM issued 3,290,570 shares of common stock for the partial compensation due to the Licensors pursuant to the License Agreement. The Company accounted for this as a research and development expense valued at $74,786. During February 2012, MBM issued an aggregate of 160,158 shares of common stock to the Licensors in connection with the anti-dilution rights to maintain a certain ownership percentage in the Company. The shares were valued at $72,799.

During the year ended February 29, 2012, MBM sold 2,989,043 shares of common stock for total proceeds of $1,943,324.

On February 27, 2012, we entered into the Exchange Agreement with MBM by issuing 18,369,421 shares of our common stock in exchange for the MBM Shares. Immediately prior to the Share Exchange, we had 840,000 shares outstanding which have been recorded as recapitalization of shareholders on MetaStat’s books at par.

During the year ended February 29, 2012, we sold 865,000 shares of common stock for proceeds of $865,000, however, $865,000 was received subsequent to February 29, 2012 and we disclosed the balance as a subscription receivable on our balance sheet as of February 29, 2012.

During the year ended February 28, 2013, the Company sold 880,000 shares of common stock for total proceeds of $880,000. Additionally, the Company issued 100,000 shares of restricted common stock to members of the board of directors for services for total expense of $5,270.

- Definition

The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.

+ References+ Details